These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25035263)

  • 21. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution.
    Kille S; Zilly FE; Acevedo JP; Reetz MT
    Nat Chem; 2011 Aug; 3(9):738-43. PubMed ID: 21860465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving regio- and enantioselectivity of P450-catalyzed oxidative CH activation of small functionalized molecules by structure-guided directed evolution.
    Agudo R; Roiban GD; Reetz MT
    Chembiochem; 2012 Jul; 13(10):1465-73. PubMed ID: 22711296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress towards the easier use of P450 enzymes.
    Chefson A; Auclair K
    Mol Biosyst; 2006 Oct; 2(10):462-9. PubMed ID: 17216026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing the efficiency and regioselectivity of P450 oxidation catalysts by unnatural amino acid mutagenesis.
    Kolev JN; Zaengle JM; Ravikumar R; Fasan R
    Chembiochem; 2014 May; 15(7):1001-10. PubMed ID: 24692265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The marmoset cytochrome P450 superfamily: Sequence/phylogenetic analyses, genomic structure, and catalytic function.
    Uehara S; Uno Y; Yamazaki H
    Biochem Pharmacol; 2020 Jan; 171():113721. PubMed ID: 31751534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cluster screening: an effective approach for probing the substrate space of uncharacterized cytochrome P450s.
    von Bühler C; Le-Huu P; Urlacher VB
    Chembiochem; 2013 Nov; 14(16):2189-98. PubMed ID: 24115388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.
    Gillam EM
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):147-52. PubMed ID: 15743395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and structural characterization of CYP109A2, a vitamin D
    Abdulmughni A; Jóźwik IK; Brill E; Hannemann F; Thunnissen AWH; Bernhardt R
    FEBS J; 2017 Nov; 284(22):3881-3894. PubMed ID: 28940959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocatalytic Enantioselective β-Hydroxylation of Unactivated C-H Bonds in Aliphatic Carboxylic Acids.
    Zhang K; Yu A; Chu X; Li F; Liu J; Liu L; Bai WJ; He C; Wang X
    Angew Chem Int Ed Engl; 2022 Jul; 61(28):e202204290. PubMed ID: 35536725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An integrated screening system for the selection of exemplary substrates for natural and engineered cytochrome P450s.
    Kanoh N; Kawamata-Asano A; Suzuki K; Takahashi Y; Miyazawa T; Nakamura T; Moriya T; Hirano H; Osada H; Iwabuchi Y; Takahashi S
    Sci Rep; 2019 Dec; 9(1):18023. PubMed ID: 31792277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What Your Crystal Structure Will Not Tell You about Enzyme Function.
    Pochapsky TC; Pochapsky SS
    Acc Chem Res; 2019 May; 52(5):1409-1418. PubMed ID: 31034199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directing group-controlled regioselectivity in an enzymatic C-H bond oxygenation.
    Negretti S; Narayan AR; Chiou KC; Kells PM; Stachowski JL; Hansen DA; Podust LM; Montgomery J; Sherman DH
    J Am Chem Soc; 2014 Apr; 136(13):4901-4. PubMed ID: 24627965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytochrome P450 enzymes and microbial drug development - A review].
    Li Z; Zhang W; Li S
    Wei Sheng Wu Xue Bao; 2016 Mar; 56(3):496-515. PubMed ID: 27382792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modeling of mammalian cytochrome P450s.
    Friedman FK; Robinson RC; Dai R
    Front Biosci; 2004 Sep; 9():2796-806. PubMed ID: 15353315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of thermostability in the cytochrome P450 fold.
    Harris KL; Thomson RES; Strohmaier SJ; Gumulya Y; Gillam EMJ
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):97-115. PubMed ID: 28822812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monooxygenation of small hydrocarbons catalyzed by bacterial cytochrome p450s.
    Shoji O; Watanabe Y
    Adv Exp Med Biol; 2015; 851():189-208. PubMed ID: 26002736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulation-Guided Design of Cytochrome P450 for Chemo- and Regioselective Macrocyclic Oxidation.
    Petrović D; Bokel A; Allan M; Urlacher VB; Strodel B
    J Chem Inf Model; 2018 Apr; 58(4):848-858. PubMed ID: 29522682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
    Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
    J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.